Psychiatr. pro Praxi, 2006; 4: 165-167

Depression, coronary artery disease, and myocardial infarction

MUDr. Jiří Podlipný
Psychiatrická klinika FN a LF UK v Plzni

There is a strong relationship between coronary artery disease (CAD) and depression. Patients after myocardial infarction often suffer from depressive disorder and this comorbidity can be explained by some common pathophysiological mechanisms. The selective serotonin reuptake inhibitors are the most feasible pharmacologic treatment of depression after myocardial infarction. It is also important to keep in mind the influence of CAD pharmaceuticals on the human psyche.

Keywords: depression, coronary artery disease, pharmacotherapy

Published: August 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Podlipný J. Depression, coronary artery disease, and myocardial infarction. Psychiatr. praxi. 2006;7(4):165-167.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Ahern L, Gorkin L, Anderson JL, et al. Biobehavioral variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS). Am J Cardiol 1990; 66: 59-62. Go to original source... Go to PubMed...
    2. Barefoot JC, Helms MJ, Mark DB, et al. Depression and long-term mortality risk in patients with coronary artery disease. Am J Cardiol 1996; 78: 613-617. Go to original source... Go to PubMed...
    3. Bruce EC, Musselman DL. Depression, alterations in platelet function, and ischemic heart disease. Psychosom Med 2005; 67, S1: S34-36. Go to original source... Go to PubMed...
    4. Bultas J: Blokátory adrenergních receptorů ? (-blokátory). In: Remedia kompendium, Panax, Praha, 1999, 3. vydání, 74-80 s.
    5. Bush DE, Ziegelstein RC, Tayback M, et al. Even minimal symptoms of depression increase mortality risk after acute myocardial infarction. Am J Cardiol 2001; 88: 337-341. Go to original source... Go to PubMed...
    6. Carney RM, Freedland KE. Depression, mortality, and medical morbidity in patients with coronary heart disease. Biol Psychiatry 2003; 54: 241-247. Go to original source... Go to PubMed...
    7. Carney RM, Freedland KE, Veith RC. Depression, the autonomic nervous system, and coronary heart disease. Psychosom Med 2005; 67(Suppl 1): S29-33. Go to original source... Go to PubMed...
    8. Centers for Disease Control and Prevention (1999). Trends in ischemic heart disease death rates for blacks and whites - United States, 1981-1995. JAMA 281: 28-29. Go to original source... Go to PubMed...
    9. Connerney PA, Shapiro PA, McLaughlin JS, et al. Relation between depression after coronary artery bypass surgery and 12-month outcome: a prospective study. Lancet 2001; 358: 1766-1771. Go to original source... Go to PubMed...
    10. Dalton SO, Johansen C, Mellemkjaer L, Norgard B, Sorenen HT, Olsen JH. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding. Arch Intern Med 2003;163: 59-64. Go to original source... Go to PubMed...
    11. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997; 350: 430-6. Go to original source... Go to PubMed...
    12. Denollet J, Brutsaert DL. Personality and mortality after myocardial infarction: Psychosom Med 1995; 57: 582-591.
    13. Frasure-Smith N, Lespérance F, Talajic M. Depression following myocardial infarction: Impact on 6 month survival. JAMA 1993; 270: 1819-1825. Go to original source... Go to PubMed...
    14. Frasure-Smith N, Lespérance F, Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation 1995; 91: 999-1005. Go to original source... Go to PubMed...
    15. Gillespie CF, Nemeroff CB. Hypercortisolemia and depression. Psychosom Med 2005; 67(Suppl 1): S26-8. Go to original source... Go to PubMed...
    16. Irvine J, Basinski A, Baker B, et al. Depression and risk of sudden cardiac death after acute myocardial infarction: testing for the confounding effects of fatigue. Psychosom Med 1999; 61: 729-737. Go to original source... Go to PubMed...
    17. Kaufmann MW, Fitzgibbons JP, Sussman EJ, et al. Relation between myocardial infarction, depression, hostility, and death. Am Heart J 1999; 138: 549-554. Go to original source... Go to PubMed...
    18. Kop WJ, Gottdiener JS. The role of immune system parameters in the relationship between depression and coronary artery disease. Psychosom Med 2005; 67, S1: S37-41. Go to original source... Go to PubMed...
    19. Ladwig KH, Kieser M, Konig J, et al. Affective disorders and survival after acute myocardial infarction. Eur Heart J 1991; 12: 959-964.
    20. Pidrman V. Deprese a kardiovaskulární onemocnění. Maxdorf, Praha, 2004, 3. vydání.
    21. Pollock BG, Laghrissi-Thode F, Wagner WR. Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment. J Clin Psychopharmacol 2000; 20: 137-40. Go to original source... Go to PubMed...
    22. Serebruany VL, Glassman AH, Malinin AI, Nemeroff CB, Musselman DL, van Zyl LT, Krishnan RR, Gaffney M, Harrison W, Finkel MS, Califf RM, O´Connor CM, Group ftS. Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline Antidepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy. Circulation 2003; 108: 939-44. Go to original source... Go to PubMed...
    23. Young-Xu Y, Chan KA, Liao JK, Ravid S, Blatt CM. Long-term statin use and psychological well-being. J Am Coll Cardiol. 2003; 42(4): 690-7. Go to original source... Go to PubMed...

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.